Trials / Completed
CompletedNCT06020287
The Robot-Assisted Laparoscopic Radical Prostatectomy Combined Anterior and Posterior Approach
The Early Therapeutic Efficacy of The Robot-Assisted Laparoscopic Radical Prostatectomy Combined Anterior and Posterior Approach: A Single-Center Retrospective Cohort Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 233 (actual)
- Sponsor
- Nanjing University School of Medicine · Academic / Other
- Sex
- Male
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The goal of this observational study was to compare the perioperative outcomes, postoperative urinary control rates and positive surgical margin (PSM) rates of the robot-assisted laparoscopic radical prostatectomy combined anterior and posterior approach (AP-RARP) with the Retzius-sparing approach (RS-RARP) and anterior approach (anterior-RARP) in the treatment of prostate cancer. The main question it aims to answer was: • The early therapeutic efficacy of the robot-assisted laparoscopic radical prostatectomy combined anterior and posterior approach Participants has been underwent: * AP-RARP * RS-RARP * anterior-RARP Researchers compared the three groups to see if AP-RARP combines the advantages of anterior and posterior RARP and is a feasible surgical option for the treatment of prostate cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | the robot-assisted laparoscopic radical prostatectomy | We collect medical data of 233 patients with clinically localized prostate cancer who underwent AP-RARP, RS-RARP or anterior-RARP. Perioperative outcomes, including operation time, intraoperative blood loss, intraoperative and postoperative transfusion, postoperative infection, and anastomotic leakage, were compared among the three groups. The postoperative continence rates and PSM rates were also compared. |
Timeline
- Start date
- 2020-09-01
- Primary completion
- 2022-05-31
- Completion
- 2022-12-27
- First posted
- 2023-08-31
- Last updated
- 2023-08-31
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06020287. Inclusion in this directory is not an endorsement.